Evidence map›Paper›PMID 19840936›Full record

ArticleThe Journal of biological chemistry2009

Genetic ablation of calcium-independent phospholipase A2{gamma} leads to alterations in hippocampal cardiolipin content and molecular species distribution, mitochondrial degeneration, autophagy, and cognitive dysfunction.

David J Mancuso, Paul Kotzbauer, David F Wozniak, Harold F Sims, Christopher M Jenkins, Shaoping Guan, Xianlin Han, Kui Yang, Gang Sun, Ibrahim Malik and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The PNPLA family of enzymes: characterisation and biological role.Arhiv za higijenu rada i toksikologiju · 2023
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Homozygous Missense Variation inMolecular syndromology · 2021
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Cardiolipin in Central Nervous System Physiology and Pathology.Cellular and molecular neurobiology · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

David J MancusoDivision of Bioorganic Chemistry and Molecular Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Paul Kotzbauer
David F Wozniak
Harold F Sims
Christopher M Jenkins
Shaoping Guan
Xianlin Han
Kui Yang
Gang Sun
Ibrahim Malik
Sara Conyers
Karen G Green
Robert E Schmidt
Richard W Gross
Institute of Bioorganic Chemistry · BYWashington University in St. Louis · USHope Center for Neurological Disorders · US

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Jennifer Lynn Powers Carson · 2013 to 2026
$27.1M
TRANSGENICS COREP60DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 1986 to 2012
$25.2M
Regulation of lipid metabolism in diabetic myocardiumP01HL057278 · NHLBI · WASHINGTON UNIVERSITY · PI GROSS, RICHARD W · 1996 to 2012
$21.8M
Washington University Center for Translational NeuroscienceP30NS057105 · NINDS · WASHINGTON UNIVERSITY · PI HOLTZMAN, DAVID M. · 2006 to 2011
$8.7M
LIPID MEDIATORS OF SIGNAL TRANSDUCTION IN SMOOTH MUSCLER01HL041250 · NHLBI · WASHINGTON UNIVERSITY · PI GROSS, RICHARD W · 1988 to 2011
$3.6M
EXPERIMENTAL DIABETIC AUTONOMIC NEUROPATHYR37DK019645 · NIDDK · WASHINGTON UNIVERSITY · PI SCHMIDT, ROBERT EDWARD · 1999 to 2004
$1.6M
EXPERIMENTAL DIABETIC AUTONOMIC NEUROPATHYR01DK019645 · NIDDK · WASHINGTON UNIVERSITY · PI SCHMIDT, ROBERT EDWARD · 1986 to 2010
$1.3M
THE ROLE OF SULFATIDES IN ALZHEIMER'S DISEASER01AG023168 · NIA · WASHINGTON UNIVERSITY · PI HAN, XIANLIN · 2005 to 2008
$1.1M
Neurodegenerative consequences of PanK2 mutationsK08NS048924 · NINDS · WASHINGTON UNIVERSITY · PI KOTZBAUER, PAUL T · 2004 to 2008
$878k
NHLBI NIH HHS P01 HL057278NHLBI NIH HHS P01 HL57278NHLBI NIH HHS R01 HL041250NHLBI NIH HHS R01 HL41250NIA NIH HHS R01 AG023168NIA NIH HHS R01 AG23168NIDDK NIH HHS DK19645-28NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK056341NIDDK NIH HHS P60 DK020579NIDDK NIH HHS R01 DK019645NIDDK NIH HHS R37 DK019645NINDS NIH HHS K08 NS048924NINDS NIH HHS NS48924NINDS NIH HHS P30 NS057105
6 · The paper itself

Abstract

Genetic ablation of calcium-independent phospholipase A(2)gamma (iPLA(2)gamma) results in profound alterations in hippocampal phospholipid metabolism and mitochondrial phospholipid homeostasis resulting in enlarged and degenerating mitochondria leading to autophagy and cognitive dysfunction. Shotgun lipidomics demonstrated multiple alterations in hippocampal lipid metabolism in iPLA(2)gamma(-/-) mice including: 1) a markedly elevated hippocampal cardiolipin content with an altered molecular species composition characterized by a shift to shorter chain length molecular species; 2) alterations in both choline and ethanolamine glycerophospholipids, including a decreased plasmenylethanolamine content; 3) increased oxidized phosphatidylethanolamine molecular species; and 4) an increased content of ceramides. Electron microscopic examination demonstrated the presence of enlarged heteromorphic lamellar structures undergoing degeneration accompanied by the presence of ubiquitin positive spheroid inclusion bodies. Purification of these enlarged heteromorphic lamellar structures by buoyant density centrifugation and subsequent SDS-PAGE and proteomics identified them as degenerating mitochondria. Collectively, these results identify the obligatory role of iPLA(2)gamma in neuronal mitochondrial lipid metabolism and membrane structure demonstrating that iPLA(2)gamma loss of function results in a mitochondrial neurodegenerative disorder characterized by degenerating mitochondria, autophagy, and cognitive dysfunction.

Indexed as

AutophagyLipid MetabolismAnimalsCardiolipinsCognition DisordersHippocampusMiceMice, KnockoutMitochondriaMitochondrial MembranesPhospholipases A2, Calcium-IndependentCardiolipinsPhospholipases A2, Calcium-Independent

Identifiers

PMID19840936
PMCPMC2790994
OpenAlexW1983617509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.